Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Microbot Medical Inc (NQ: MBOT ) 0.9800 +0.0150 (+1.55%) Streaming Delayed Price Updated: 3:59 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Microbot Medical Inc < Previous 1 2 3 4 5 6 Next > Looking Into Microbot Medical's Recent Short Interest February 02, 2024 Via Benzinga Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters January 30, 2024 All of the cash payable to the plaintiffs in the settlement will be covered by Microbot’s insurance carrier and will not impact company's cash position From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study January 18, 2024 Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical study From Microbot Medical Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session January 01, 2024 Via Benzinga Gold Moves Lower; Microbot Medical Shares Slide December 29, 2023 U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The... Via Benzinga Topics Stocks Exposures US Equities Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 29, 2023 Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 29, 2023 Via Benzinga Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet December 29, 2023 U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Friday. The Dow traded down 0.34% to 37,583.72 while the NASDAQ fell 0.73% to 14,984.98. The... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Friday's Pre-Market Session December 29, 2023 Via Benzinga Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules December 29, 2023 From Microbot Medical Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session December 28, 2023 Via Benzinga Gold Moves Lower; US Crude Stocks Decline Last Week December 28, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90.... Via Benzinga Topics Stocks Exposures US Equities Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 28, 2023 Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 28, 2023 Via Benzinga Crude Oil Down 1%; US Wholesale Inventories Fall In November December 28, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up 0.14% to 37,708.15 while the NASDAQ rose 0.19% to 15,127.17. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Microbot Medical Stock Is Moving Higher: What's Going On? December 28, 2023 Microbot Medical Inc (NASDAQ: MBOT) shares are trading higher Thursday after the company announced the completion of its GLP pivotal pre-cl Via Benzinga Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met December 28, 2023 The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study From Microbot Medical Inc. Via GlobeNewswire Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic December 14, 2023 The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular treatments From Microbot Medical Inc. Via GlobeNewswire 3 Stocks at the Forefront of Medical Robotics December 10, 2023 Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid. Via InvestorPlace Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study December 07, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities November 21, 2023 The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase. From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process November 13, 2023 The V&V process is an additional key milestone toward regulatory submission and is required to continue the regulatory process with the FDA From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office November 08, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study October 31, 2023 Follow up visual examination three days after the procedures using the LIBERTY Robotic Surgical System, confirms 100% success rate in reaching the targets with no adverse events From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024 October 24, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company October 19, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System October 17, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial September 27, 2023 The engagement is an additional step in the Company's path towards marketing clearance with the FDA From Microbot Medical Inc. Via GlobeNewswire Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket September 20, 2023 Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday. Via Benzinga Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023 September 08, 2023 The presentation follows successful extensive uses of the Company’s endovascular robotic system in pre-clinical studies From Microbot Medical Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.